AXSOME
LIVE

Serial Number

98475314

Owner

Axsome Therapeutics, Inc.

Attorney

Brent Johnson

Filing Date

Mar 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AXSOME Trademark

Serial Number: 98475314

AXSOME is a trademark filed by Axsome Therapeutics, Inc. on March 29, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Axsome Therapeutics, Inc. (69 trademarks)

New York, NY 10007

Entity Type: 03

Trademark Details

Filing Date

March 29, 2024

Registration Date

Not Registered

Published for Opposition

November 19, 2024

Goods & Services

Providing an on-line forum for patients and doctors to communicate and discuss depression and treatments for depression

Downloadable cloud-based software for the purpose of tracking, managing and storing information related to medications and medication compliance, patient health, wellness and symptoms, and patient diseases and disorders; Downloadable software in the nature of a mobile application for the purpose of tracking, managing and storing information related to medications and medication compliance, patient health, wellness and symptoms, and patient diseases and disorders

Promoting public awareness of migraines

Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, depression, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss

Printed educational materials in the field of migraines

Consulting services in the field of health relating to pharmaceuticals; Providing health information relating to pharmaceuticals; Providing health information relating to pharmaceuticals via a website; Providing medical information relating to pharmaceuticals via a website; Providing news and information in the field of medicine relating to pharmaceuticals; Providing on-line information, news and commentary in the field of health and wellness relating to pharmaceuticals; Providing health information; providing health information via a website; providing medical information via a website; providing medical information in the field of depression and treatments for depression; providing mental health information via a website; providing mental health and wellness information; providing news and information in the field of medicine; providing news and information in the field of mental health about depression and treatments for depression; providing on-line information, news and commentary in the field of health and wellness relating to depression and treatments for depression; Providing healthcare information in the field of migraines; Providing healthcare information in the field of migraines via a website

Management of pharmacy benefit programs featuring a medical benefit co-pay card; Financial administration of patient assistance eligibility programs featuring a pharmacy benefit co-pay card; providing financial assistance in the form of prepaid co-pay cards to patients for medical benefits

Filing History

TEAS PETITION TO DIRECTOR RECEIVED
Jun 18, 2026 TPDR
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 14, 2026 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 2, 2026 AITU
TEAS STATEMENT OF USE RECEIVED
Dec 11, 2025 EISU
SOU TEAS EXTENSION RECEIVED
Dec 11, 2025 EEXT
TEAS REQUEST TO DIVIDE RECEIVED
Dec 11, 2025 ERTD
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 18, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 18, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 18, 2025 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 24, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 23, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 23, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 23, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 2, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 2, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 2, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 2, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 2, 2025 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 31, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 15, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 15, 2024 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 11, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 11, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 11, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 11, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 11, 2024 CNEA
ASSIGNED TO EXAMINER
Oct 9, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 3, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2024 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 15, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 15, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 15, 2024 REAP
NEW APPLICATION ENTERED
Mar 29, 2024 NWAP